SMTK · SmartKem, Inc.

The transactions announced represent a critical milestone for SmartKem, addressing immediate Nasdaq delisting risk while securing significant long-term capital flexibility. The initial private placement is expected to cure the $2.5 million stockholders' equity deficiency that had put the company at risk of delisting, though formal confirmation from Nasdaq is still pending. The $500 million equity line of credit provides the company with access to substantial additional capital on an as-needed basis, supporting working capital needs and potential strategic initiatives without immediate forced dilution. Key terms include limitations on future equity issuances below the Series A conversion price for three years, and requirements to seek stockholder approval for an increase in authorized common shares to 5 billion, a reverse stock split, and removal of written consent restrictions within 60 days of closing. The financing also includes customary registration rights obligations, with cash penalties for the company if it fails to file and maintain effective registration statements for the resale of shares issued in the transactions.